Evidence map›Paper›PMID 18802019›Full record

SynthesisArteriosclerosis, thrombosis, and vascular biology2008

Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13.

Ralph Burkhardt, Eimear E Kenny, Jennifer K Lowe, Andrew Birkeland, Rebecca Josowitz, Martha Noel, Jacqueline Salit, Julian B Maller, Itsik Pe'er, Mark J Daly and 4 more

Open access · greenAbstract readMeta-Analysis
In one paragraph

Synthesis in Arteriosclerosis, thrombosis, and vascular biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 2 syntheses or guidelines pooled it, 134 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Alternative Splicing Regulation in Metabolic Disorders.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2025
    Review
  6. Article
  7. Genetic Polymorphisms in theInternational journal of molecular sciences · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Therapeutic targets of hypercholesterolemia: HMGCR and LDLR.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  19. Article
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Ralph BurkhardtLaboratory of Biochemical Genetics and Metabolism, The Rockefeller University, New York, NY 10065, USA.
Eimear E Kenny
Jennifer K Lowe
Andrew Birkeland
Rebecca Josowitz
Martha Noel
Jacqueline Salit
Julian B Maller
Itsik Pe'er
Mark J Daly
David Altshuler
Markus Stoffel
Jeffrey M Friedman
Jan L Breslow
Center for Human Genetics · USColumbia University · USHarvard University · USBroad Institute · USMassachusetts General Hospital · US

Funding

GENETIC BASIS OF SYNDROME X ON THE ISLAND OF KOSRAER01DK056208 · NIDDK · ROCKEFELLER UNIVERSITY · PI FRIEDMAN, JEFFREY M · 2000 to 2002
$2.4M
Howard Hughes Medical InstituteNIDDK NIH HHS R01 DK056208
6 · The paper itself

Abstract

unlabelledBackground- Variation in LDL-cholesterol (LDL-C) among individuals is a complex genetic trait involving multiple genes and gene-environment interactions. METHODS AND

resultsIn a genome-wide association study (GWAS) to identify genetic variants influencing LDL-C in an isolated population from Kosrae, we observed associations for SNPs in the gene encoding 3hydroxy-3-methylglutaryl (HMG)-coenzyme A (CoA) reductase (HMGCR). Three of these SNPs (rs7703051, rs12654264, and rs3846663) met the statistical threshold of genome-wide significance when combined with data from the Diabetes Genetics Initiative GWAS. We followed up the association results and identified a functional SNP in intron13 (rs3846662), which was in linkage disequilibrium with the SNPs of genome-wide significance and affected alternative splicing of HMGCR mRNA. In vitro studies in human lymphoblastoid cells demonstrated that homozygosity for the rs3846662 minor allele was associated with up to 2.2-fold lower expression of alternatively spliced HMGCR mRNA lacking exon13, and minigene transfection assays confirmed that allele status at rs3846662 directly modulated alternative splicing of HMGCR exon13 (42.9+/-3.9 versus 63.7+/-1.0%Deltaexon13/total HMGCR mRNA, P=0.02). Further, the alternative splice variant could not restore HMGCR activity when expressed in HMGCR deficient UT-2 cells.

conclusionsWe identified variants in HMGCR that are associated with LDL-C across populations and affect alternative splicing of HMGCR exon13.

Indexed as

Alternative SplicingCholesterol, LDLExonsHydroxymethylglutaryl CoA ReductasesPacific Island PeoplePolymorphism, Single NucleotideWhite PeopleAnimalsCHO CellsCricetinaeCricetulusGenotypeHomozygoteHumansLinkage DisequilibriumLymphocytesCholesterol, LDLHydroxymethylglutaryl CoA ReductasesRNA, Messenger

Identifiers

PMID18802019
PMCPMC2764366
OpenAlexW2135147724

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.